Many in vitro experiments have shown that using the plasmids or adenoviruses strategy to deliver wild-type human B2M gene into melanoma cells or other tumor cells can restore tumor cell HLA class I antigen expression and peptide-specific T lymphocyte recognition (24, 29, 30, 37, 72). Here, B2M is linked to melanoma.